Newsletter | March 18, 2026

03.18.26 -- Advance Your MSC Process: New Research, Expert Talks, And Scaling Solutions

A Journey Of MSC-Derived Therapies From Isolation To Large-Scale

Master the transition from isolation to large-scale production. Focus on optimizing surface chemistry and closed-system technologies to maintain cellular stability during therapeutic scale-up.

 

Reducing Manufacturing Risks In Scalable Cell Therapy Production

Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.

 

Navigating Cell Culture Vessels: A Collection Of Application Notes

Explore scalable strategies for high-yield adherent cell culture. Learn how gas-permeable technology optimizes MSC expansion, viral vector production, and extracellular vesicle secretion.

 

Genetically Modified MSCs For The Treatment Of GvHD

Discover how genetically engineered MSCs are significantly advancing GvHD treatment. See the preclinical success with CXCR4-IL10-MSCs and the process for scaling up their GMP production.

 

BIO-EXPO LIVE VIDEO FEATURE

Streamlining Bioprocess Efficiency For High-Yield MSC Production

Watch how this specialized platform streamlines mesenchymal stem cell production. This presentation highlights how to maximize cell yield and achieve efficient, scalable manufacturing.

 

SOLUTIONS

Modular Closed-System Platform For Adherent Cells

Optimize adherent cell expansion with modular, closed-system platforms that provide high surface area, uniform nutrient delivery, and automated perfusion to ensure consistent cellular quality.

• Request Information

 

 

 

High-Yield Vessels For Reliable Laboratory Output

Enhance your production with a closed-system vessel designed for sensitive applications. Achieve consistent, reliable performance and ease of use in high-density cellular growth environments.

• Request Information